MedTrace Logo

Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support

NCT05276531 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2022-09-09

No results posted yet for this study

Summary

The invesigators aimed to seperate the patients,which is going to be applied IUI, to two different groups as prospective randomized controlled ;assess the efficacy of the two different way pressurised progesterone by appling intravaginal progesterone to the first group; subcutaneous to the second group.

Conditions

  • Progesterone

Interventions

DRUG

subcutaneous progesterone

clinical pregnancy rates

DRUG

vaginal progesterone

clinical pregnancy rates

Sponsors & Collaborators

  • Bezmialem Vakif University

    lead OTHER

Principal Investigators

  • Gurkan Kiran, MD · Bezmialem Vakif University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-06-01
Completion
2022-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05276531 on ClinicalTrials.gov